Pain Point, Solved 4.9 ★★★★★ Google Rating

Why Do Spravato Claims Pay Partially, Covering the Visit but Not the Drug or Observation Line?

All Pain Points

Ask AI about this page

Spravato claims pay partially because the session is three linked components, the drug line, the evaluation and management or session code, and the observation, and each has to be coded correctly and tied under one diagnosis, with the drug code itself differing by payer. The easy part, the visit, pays; the drug line, the expensive part, is where the coding trips. A biller unfamiliar with the structure splits the claim, uses the wrong drug code family for that payer, or bills the drug with the wrong units, and the drug line pends or denies while the visit sails through. The fix has four moves: build the three parts correctly under one diagnosis every time, select the right drug code for that specific payer, work every stuck drug line to its real reason instead of writing it off, and reconcile the drug reimbursement against what was administered so nothing quietly goes unpaid. We run those moves inside your billing system, so the whole session pays, not just the cheap part. The table of contents maps the whole method; the moves after it are the detail.

How to Get the Whole Spravato Session Paid, Not Just the Visit
Key Pain Points and Discussions by Providers
Why This Keeps Happening
The Solution
How We Permanently Fix the Process
The Whole Thing in Four Sentences
Frequently Asked Questions
Where the Claims on This Page Come From

How to Get the Whole Spravato Session Paid, Not Just the Visit

The goal is a fully paid session: the visit, the drug, and the observation, all landing together instead of the drug line quietly stuck. Here is what does that, move by move.

1. Build the Three Parts Correctly Under One Diagnosis

A Spravato session is not one line, it is a linked set: the drug, the session or evaluation and management component, and the two-hour observation, all tied under the same depression diagnosis. When a biller splits them, bills them under mismatched diagnoses, or drops the observation, the payer’s edits catch the break and the drug line is the first to stall. The first move is a standard build every time: the three components assembled together, linked to one diagnosis, so the claim reads as the single bundled service the payer expects.

2. Select the Right Drug Code for That Specific Payer

This is where the money is won or lost. The correct drug code for Spravato differs by payer type, and the codes changed in 2026, so a code family that was right last year, or right for one payer, is wrong for another. Medicare and many plans expect the session codes that bundle the drug and observation, while other payers expect the per-milligram drug code billed in units matching the dose. Picking the wrong family, or billing the wrong units for the dose, is the single most common reason a drug line denies while the visit pays. The fix is a payer-by-payer code map, not a habit.

3. Work Every Stuck Drug Line to Its Real Reason

A pending or denied drug line is not a lost cause; it is a message. Under it sits a specific reason: wrong code family for the payer, unit mismatch to the dose, a diagnosis link the payer rejected, or a missing prior authorization reference. Working it means reading that reason, correcting the specific defect, and resubmitting, not rebilling the same thing and hoping. Because the visit already paid, these lines are easy to ignore, which is exactly why they pile up into five-figure underpayment before anyone looks.

4. Reconcile Drug Reimbursement Against What Was Administered

The only way to know a drug line got paid is to check it against what went into the patient. A standing reconciliation matches every dose administered to the reimbursement received: this many 56 mg and 84 mg sessions delivered, this much drug reimbursement landed, here is the gap. That reconciliation is what turns an invisible leak into a worked queue. Without it, the visit paying every time masks a drug line that has been quietly short for months, and the loss only surfaces when someone finally adds it up.

5. Hand Spravato Billing to a Dedicated Team

Practices that stop losing drug reimbursement do it by handing Spravato billing to a dedicated team: remote specialists who build the three-part claim, code the drug for each payer, work the stuck lines, and reconcile against administration, live in 1 to 2 weeks. The providers go back to treating patients, a trained backup covers every gap, and the drug line stops being the thing nobody watches. Below is what it sounds like when nobody owns this yet, in providers’ own words.

Key Pain Points and Discussions by Providers

real reports from practice staff, lightly edited

“Our office visits paid every single time, so we thought Spravato billing was fine. Then I actually pulled the drug lines and half of them were pending or denied going back months. Five figures of drug reimbursement just sitting there because the visit paying hid the whole problem.” – billing lead, interventional psychiatry clinic

“The drug code is not the same for every payer, and once the codes changed our biller kept using the old family for a plan that wanted the new one. Every one of those drug lines denied while the E and M sailed through. It took us far too long to see the pattern.” – revenue cycle manager, Spravato treatment center

“Nobody told our biller that Spravato is three linked pieces, not one line. She was billing the drug separate from the visit under a slightly different diagnosis, and the payer’s edits killed the drug line every time. The visit was clean, so it never got flagged.” – practice administrator, psychiatry group

“The units are the trap for us. An 84 mg dose has to be billed the right way for the payer, and a unit mismatch denies the drug line silently. We were reconstructing which sessions actually got the drug paid and it was a mess because nobody was reconciling doses to payments.” – coder, behavioral health practice

“I learned to reconcile drug reimbursement against every dose we administered. The month I started doing that we found a whole payer whose drug lines had never paid correctly. Until you match administered to paid, the visit paying every time convinces you nothing is wrong.” – billing manager, Spravato clinic

Our Answer

Here is what we actually do. A dedicated remote specialist builds every Spravato claim as the three linked pieces it is, the drug, the session or evaluation and management component, and the observation, tied under one depression diagnosis, and selects the drug code that matches that specific payer and the current code set, in the correct units for the dose. When a drug line pends or denies, they read it to its real reason, correct the defect, and resubmit, instead of rebilling blind. And they reconcile drug reimbursement against every dose administered, so a short-paid payer surfaces the same month, not six months later. Our specialists are credentialed professionals, overseas-trained physicians and US-licensed nurses and pharmacists, working inside your billing system and payer portals, with AI drafting the first-pass claim and a human verifying every drug line. This is our medical billing and denials management paired with an AI-first workflow, in one paragraph.

Why This Keeps Happening

If the visit pays, why does the drug line stick? Because the visit is the simple part and the drug is the managed part. A Spravato session bills as a linked set of components under one diagnosis, and the drug code itself differs by payer type, with Medicare and many plans expecting session codes that bundle the drug and observation while others expect a per-milligram drug code billed in units. The codes also changed in 2026, retiring an older temporary code in favor of a permanent one, so a code that was correct last year can be wrong now. A biller who has not learned that structure codes the drug the way that feels natural, and the payer’s edits reject it while the visit clears.

The reason it goes unnoticed is the asymmetry. The evaluation and management or session component pays reliably, so the remittance looks like a working claim, and nobody scrolls down to the drug line that pended. Because Spravato is high volume in an active clinic, a small per-session leak compounds fast, and by the time anyone reconciles, the underpayment is real money. A dedicated revenue cycle workflow exists precisely to watch the line that is easy to ignore.

And the cost is not just aged accounts receivable. The Spravato drug is the most expensive part of the session, so a stuck drug line is not a small write-off, it is the majority of the session’s value sitting unpaid. Multiply that by a growing census and a payer whose drug lines have never coded correctly, and the leak that hid behind a clean visit becomes a five-figure hole traced to one wrong code family. That is revenue the clinic earned, delivered the drug for, and simply never collected.

⚠️ The quiet one that hurts most: The quiet one that hurts most: the clean visit that hides a stuck drug. Because the evaluation and management line pays every time, the remittance looks healthy and nobody looks past it. The drug line, the expensive part, can pend or deny for months without anyone noticing, and by the time a reconciliation catches it, the underpayment is spread across every session that shared the wrong code. It never announces itself, because the part everyone checks kept paying. Unless someone reconciles drug reimbursement against what was actually administered, the most expensive part of the session is the part most likely to go quietly unpaid.

Most groups have already tried the obvious fixes before they talk to anyone. Each one fails the same way: the work lands back on the practice. The pattern, in one table:

What you tried	What actually happened	Who ended up doing the work
Assumed billing was fine because the office visits paid	The drug lines pended for months behind clean visits until a reconciliation found five figures unpaid	A remittance nobody scrolled past
Kept using the same Spravato drug code for every payer	Denied for the payers whose code family differed, especially after the 2026 code change	A habit that ignored payer rules
Rebilled the stuck drug lines unchanged	Bounced on the same defect because the wrong code or units were never corrected	Whoever reworked the queue that week
Gave Spravato billing to a dedicated remote specialist	Three-part claim built right, drug coded per payer, stuck lines worked, doses reconciled to payments	Someone whose whole job it is

The Solution

So what does “someone whose whole job it is” look like on a stuck Spravato drug line? The specialist starts with the build: the three components, drug, session or evaluation and management, and observation, assembled together and linked under one depression diagnosis, so the claim reads as the bundled service the payer expects. Then they select the drug code for that specific payer and the current code set, in the correct units for the dose, because the code that is right for one payer is wrong for another. Getting the claim right at first submission is the whole point of dedicated medical billing, and it is where most of the drug-line denials never happen.

When a drug line still pends or denies, the specialist reads it to its real reason, wrong code family, unit mismatch, rejected diagnosis link, missing authorization reference, corrects that specific defect, and resubmits, instead of rebilling blind. And they run a standing reconciliation that matches every administered dose to the reimbursement received, so a payer whose drug lines are short surfaces the same month rather than in a year-end surprise. The visit paying every time no longer hides a drug line that has been quietly stuck.

Behind all of it, AI drafts the first-pass claim and a credentialed human verifies. The workflow assembles the linked components, applies the payer-specific drug code, and flags any unit or diagnosis mismatch; a person confirms the drug line is right before it goes out and owns every stuck line. Every security control that protects the chart and claim data moving through that process is documented and auditable, and the whole approach is described on our HIPAA and security page, because moving clinical and billing information through a claims workflow is only safe when the controls are real.

Who Actually Does This Work

Fair question: why would an outsourced team collect your Spravato drug lines better than your own biller? Because the payer-by-payer drug coding and the stuck-line follow-up is their entire day, not the thing they fit around every other claim in the practice. The people working your Spravato billing are credentialed medical professionals: overseas-trained physicians, US-licensed nurses and pharmacists, and PharmDs, all trained in US medical billing and interventional psychiatry coding. They know that Spravato is a three-part claim, that the drug code differs by payer and changed in 2026, and how to work a stuck drug line to its real reason. That is not a task for whoever has a free minute; it is a specialty.

We are not a call center. We are a clinical operations partner, a healthcare BPO built on dedicated virtual staff: 500+ credentialed professionals, 24/7 coverage, and the AI-first-pass plus human-verify workflow you just read about behind every one of them. A typical clinic is live in 1 to 2 weeks, at up to 70% below the cost of hiring locally, and no one on our side goes out without a trained backup already inside your workflow, so a stuck drug line never sits because the one person who works Spravato billing is on vacation.

And the security piece your compliance officer will ask about: we are audited to SOC 2 Type II with zero exceptions and certified for ISO/IEC 27001:2022, HIPAA, and GDPR, with zero breaches in eight years. Every workstation runs inside a secure enclave on US-based servers, with screen captures and downloads blocked by policy, so PHI never sits on someone’s home laptop. Every client account carries a $5M E&O and cyber liability policy and a BAA signed before any work starts; the full detail lives in our HIPAA and security posture.

Put the routine and the people together, and a specific list of things simply stops happening.

✓ What stops happening: What stops happening: the drug line that pends for months behind a clean visit. The wrong code family used for a payer that wanted a different one, especially after the code change. The three-part claim split under mismatched diagnoses. The unit mismatch that denies an 84 mg dose silently. The five-figure underpayment nobody saw because the office visit kept paying and no one reconciled the drug against what was administered.

2-Week Free Trial

Ready to Get Your Whole Spravato Session Paid?

Book A Strategy Call Request Information

How We Permanently Fix the Process

A person alone is not the fix, and neither is a code sheet alone. The fix is a documented Spravato billing workflow: how the three components are assembled and linked, the payer-by-payer drug code map kept current with the code changes, the way a stuck drug line is worked to its reason, and the reconciliation that matches doses to payments, all written down and worked the same way every time. Before we take a single claim for a new clinic, we pull your Spravato drug lines by payer so we can see exactly where the reimbursement is sticking, and we build the workflow against that, not against a generic template.

From there the workflow becomes a living playbook rather than one biller’s habit. It records how each payer wants the session coded, which drug code and units apply, how the components link under one diagnosis, and the reconciliation that catches a short-paid payer the same month. It is written down, kept current as the codes and payer rules change, and owned by the team. When your specialist is out, a trained backup works the same playbook the same way, so a drug line never sits stuck because one person was away.

That is the difference between reworking this month’s denials and fixing the process for good, and it is what a dedicated revenue cycle management partner actually buys you. A biller leaving used to mean the drug lines started sticking again behind clean visits. Under this model the workflow keeps running, the playbook stays, the backup steps in, and the Spravato drug line stops being the expensive part that quietly goes unpaid.

The Whole Thing in Four Sentences

Spravato claims pay partially because the session is three linked components, the drug, the visit, and the observation, tied under one diagnosis, and the drug code differs by payer and changed in 2026, so a biller unfamiliar with the structure splits or miscodes the drug and it pends while the visit pays. Assuming billing is fine because the visits pay, reusing one drug code for every payer, or rebilling stuck lines unchanged all fail the same way. The fix is to build the three parts correctly under one diagnosis, code the drug for the specific payer in the right units, work every stuck line to its real reason, and reconcile reimbursement against every dose administered. An interventional psychiatry group running Spravato uses exactly this model with us today, names withheld, no patient data shown.

If you want to check us out before talking to anyone: our security posture is independently auditable, we are an MGMA 2026 Corporate Member, and 800+ providers run back office work with us.

Ready to get your whole Spravato session paid? Try us risk free: two weeks, your real Spravato drug-line queue, dedicated specialists coding the drug per payer and working the stuck lines, and if it does not earn the handoff, you walk away. From here down is the sales part, and it is short: here is exactly what it costs.

Transparent Weekly Pricing

One Flat Weekly Rate. 45 Hours of Coverage.

No hourly meters, no setup fees, no long-term contracts. Your dedicated team member covers your desk 45 hours every week, and a trained backup steps in at no charge whenever they are out.

Single

$399/ week

One dedicated remote specialist building three-part Spravato claims and working stuck drug lines end to end, single-site treatment center

Collect Your Stuck Drug Lines This Month

You have seen the whole method. The pilot proves it on your own Spravato drug-line queue, with a tracker your team can watch every day.

Start My 2-Week Free Trial

Request Information or call directly: (800) 489-5877

Request Information

Single specialty or multi-site? One payer or many? Tell us your situation and we will map the right coverage within 24 hours.

Frequently Asked Questions

Why does my Spravato office visit pay but the drug line pend or deny?

Because the session is three linked components, the drug, the evaluation and management or session code, and the two-hour observation, tied under one depression diagnosis, and the drug is the managed, expensive part. The visit codes the way a biller expects and pays reliably, but the drug code differs by payer type and changed in 2026, so an unfamiliar biller often picks the wrong code family or the wrong units for the dose. The payer’s edits reject the drug line while the visit clears, and because the visit paid, nobody notices the drug line stuck.

Why is the Spravato drug code different for different payers?

Because payers handle the bundled esketamine session differently. Medicare and many commercial plans expect the session codes that bundle the drug and the two-hour observation, while other payers expect the per-milligram drug code billed in units that match the dose. On top of that, the code set changed in 2026, retiring an older temporary code in favor of a permanent one for non-Medicare payers. A single drug code used for every payer will deny for the ones whose rules differ, which is why the code has to be mapped payer by payer.

How do we recover Spravato drug reimbursement that already denied?

Work each stuck drug line to its real reason rather than rebilling it unchanged. Under a pended or denied drug line sits a specific defect: wrong code family for the payer, a unit mismatch to the dose, a rejected diagnosis link, or a missing authorization reference. Correct that specific defect and resubmit. Then run a reconciliation that matches every administered dose to the reimbursement received, which surfaces any payer whose drug lines have been short so you can rework them before the filing window closes.

How do we catch Spravato underpayment before it becomes five figures?

Reconcile drug reimbursement against what was administered every month. The visit paying reliably hides a drug line that may be silently short, so the only way to see the leak is to match doses delivered to payments received: this many 56 mg and 84 mg sessions, this much drug reimbursement, here is the gap. That reconciliation turns an invisible leak into a worked queue and catches a mis-coded payer the same month instead of at year-end.

How much does outsourced Spravato billing cost?

Staffingly charges a flat weekly rate per dedicated remote specialist, with lower per-person rates for teams of 5 or more and 10 or more. Every plan covers 45 hours of coverage per week with a trained backup included, and there is no percentage of your collections. The pricing section on this page shows how the flat rate compares with typical US market rates for this work.

Will AI be coding our Spravato claims?

No. AI drafts the first-pass claim, assembling the linked components, applying the payer-specific drug code, and flagging unit or diagnosis mismatches, and a credentialed human verifies every drug line before it goes out and owns every stuck line. The coding judgment stays with people. Automation removes the repetitive assembly so the specialist spends their time on the lines that need a human, not on retyping the same claim structure.

Do we have to change our billing system?

No. Our specialists work inside the billing system and payer portals you already use, so there is no migration and no new platform for your team to learn. They build and submit claims where your work already lives, which is why a typical clinic is live in 1 to 2 weeks rather than months.

How fast will we see the drug lines start paying?

Usually within the first two weeks. Once a dedicated specialist is building the three-part claim correctly, coding the drug for each payer, and working the stuck lines to their real reason, the drug lines that used to pend behind clean visits start clearing, and the reconciliation surfaces any payer that was short so it gets reworked instead of written off.

How does one flat weekly rate cover 45 hours every week?

Your dedicated specialist works a 9-hour day, Monday to Friday, which is 45 hours of coverage each week. The ninth hour is part of the flat weekly rate, not billed as overtime. Over a year that is 2,340 hours of coverage, against the standard US full-time work year of 2,080 hours (40 hours x 52 weeks, the same basis the U.S. Office of Personnel Management uses to compute hourly rates of pay). That is how $399 per week works out to $8.87 per hour.

Written By

Dan Nandan

Founder and CEO, Staffingly, Inc. · Piscataway, NJ

Dan Nandan has spent 25+ years in IT consulting and healthcare BPO, was among the first in the US to build an RPO/BPO delivery network in India, and has been featured in Computerworld. He runs the operations and the dedicated virtual teams behind the workflows on this page; the team-voice answers above come from the remote specialists who work them every day.

Connect on LinkedIn

Where the Claims on This Page Come From

Sources & References

Centers for Medicare and Medicaid Services, Esketamine Billing and Coding Article. CMS guidance on Spravato session billing, the bundled drug-and-observation session codes, and coverage rules. cms.gov
American Medical Association CPT and HCPCS Coding Resources. Authoritative coding references for evaluation and management, drug administration, and observation components of a bundled service. ama-assn.org
HFMA Revenue Cycle and Denials Management Resources. Guidance on partial-payment denials, drug-line underpayment recovery, and reconciliation of high-cost drug reimbursement. hfma.org
MGMA Revenue Cycle and Practice Operations Resources. Benchmarks and guidance on billing workflows and denial management for medical group practices. mgma.com
US Food and Drug Administration, Spravato Prescribing Information. Dosing information for the 56 mg and 84 mg esketamine sessions relevant to unit-based drug billing. accessdata.fda.gov